Recent Advances in the Development of Bio-Reducible Polymers for Efficient Cancer Gene Delivery Systems
- PMID: 31032485
- PMCID: PMC6481959
Recent Advances in the Development of Bio-Reducible Polymers for Efficient Cancer Gene Delivery Systems
Abstract
Gene therapy is the unique method for the use of genetic materials such as Messenger ribonucleic acid (mRNA), plasmid deoxyribonucleic acid (pDNA), and small interfering ribonucleic acid (siRNA) into specific host-cells for the treatment of inherited disorders in any diseases. The successful way to utilize the gene therapy is to develop the efficient cancer gene delivery systems. In this paper, the successful and efficient gene delivery systems are briefly reviewed on the basis of bio-reducible polymeric systems for cancer therapy. The viral gene delivery systems such as RNA-based viral and DNA-based viral vectors are also discussed. The development of bio-reducible polymer for gene delivery system has briefly discussed for the efficient cancer gene delivery of viral vectors and non-viral vectors.
Keywords: Bio-reducible polymer; Cancer gene therapy; Gene delivery systems; PEI-conjugated polymer; RNA/DNA.
Similar articles
-
Tumor targeting RGD conjugated bio-reducible polymer for VEGF siRNA expressing plasmid delivery.Biomaterials. 2014 Aug;35(26):7543-52. doi: 10.1016/j.biomaterials.2014.05.021. Epub 2014 Jun 2. Biomaterials. 2014. PMID: 24894645 Free PMC article.
-
Recent advances in polymeric drug delivery systems.Biomater Res. 2020 Jun 6;24:12. doi: 10.1186/s40824-020-00190-7. eCollection 2020. Biomater Res. 2020. PMID: 32537239 Free PMC article. Review.
-
Well-defined reducible cationic nanogels based on functionalized low-molecular-weight PGMA for effective pDNA and siRNA delivery.Acta Biomater. 2016 Sep 1;41:282-92. doi: 10.1016/j.actbio.2016.06.006. Epub 2016 Jun 3. Acta Biomater. 2016. PMID: 27267781
-
Design of PEI-conjugated bio-reducible polymer for efficient gene delivery.Int J Pharm. 2018 Jul 10;545(1-2):295-305. doi: 10.1016/j.ijpharm.2018.04.051. Epub 2018 Apr 23. Int J Pharm. 2018. PMID: 29698820 Free PMC article.
-
Recent advances in the development of gene delivery systems.Biomater Res. 2019 Mar 12;23:8. doi: 10.1186/s40824-019-0156-z. eCollection 2019. Biomater Res. 2019. PMID: 30915230 Free PMC article. Review.
Cited by
-
Hybrid polymers bearing oligo-l-lysine(carboxybenzyl)s: synthesis and investigations of secondary structure.RSC Adv. 2020 Jan 7;10(3):1287-1295. doi: 10.1039/c9ra09189k. eCollection 2020 Jan 7. RSC Adv. 2020. PMID: 35494681 Free PMC article.
-
Adeno-associated virus vector modification based on directed evolution technology for gene therapy targeting head and neck squamous cell carcinoma.Front Oncol. 2025 Jun 3;15:1566584. doi: 10.3389/fonc.2025.1566584. eCollection 2025. Front Oncol. 2025. PMID: 40530007 Free PMC article.
-
Initial Screening of Poly(ethylene glycol) Amino Ligands for Affinity Purification of Plasmid DNA in Aqueous Two-Phase Systems.Life (Basel). 2021 Oct 26;11(11):1138. doi: 10.3390/life11111138. Life (Basel). 2021. PMID: 34833014 Free PMC article.
References
-
- Kim SW, Nam JP, Kim S, et al. (2018) Recent development of bio-reducible polymers for efficient gene delivery system. Journal Cancer Treatment & Diagnosis 2(5): 17–23.
-
- Sung YK, Kim SW (2018) Advances in the application of poly (ethylenimine) conjugated bio-reducible dendrimers for gene delivery systems. Medical Research Archives 6(12): 1–9.
-
- Sung YK, Kim SW (2018) The practical application of gene vectors in cancer therapy. Integrative Cancer Science & Therapeutics 5(5): 1–5.
-
- Han SO, Mahato RI, Sung YK, et al. (2000) Development of biomaterials for gene therapy. Molecular Therapy 2(4): 302–317. - PubMed
Grants and funding
LinkOut - more resources
Full Text Sources